Edinburgh, United Kingdom

Malcolm Douglas Walkinshaw

This inventor holds 1 USPTO granted patent. Top assignee: Cyclacel Limited. Active years: 2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Malcolm Douglas Walkinshaw. Retrieved from https://idiyas.com/inventor/malcolm-douglas-walkinshaw

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Malcolm Douglas Walkinshaw

Introduction

Malcolm Douglas Walkinshaw is a notable inventor based in Edinburgh, GB. He has made significant contributions to the field of biochemistry, particularly through his innovative work on peptide derivatives. His expertise and dedication to research have led to the development of valuable compounds that have potential applications in various industries.

Latest Patents

Malcolm Douglas Walkinshaw holds a patent for "Modified peptide derivatives and methods of use thereof." This invention relates to a compound of formula I, wherein the substituents are defined in the specification. His work in this area showcases his commitment to advancing scientific knowledge and practical applications.

Career Highlights

Walkinshaw is associated with Cyclacel Limited, a company that focuses on developing innovative cancer therapies. His role at Cyclacel Limited has allowed him to collaborate with other talented professionals in the field, further enhancing his contributions to biochemistry and pharmaceutical research.

Collaborations

Some of his notable coworkers include Paul A Taylor and Nicholas Turner. Their collaborative efforts have likely contributed to the success of various projects and innovations within the company.

Conclusion

Malcolm Douglas Walkinshaw's work exemplifies the spirit of innovation in the field of biochemistry. His patent and contributions to Cyclacel Limited highlight his dedication to advancing scientific research and developing new therapeutic solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…